Home > Cashflow Statement > WINDLAS BIOTECH

WINDLAS BIOTECH
Cash Flow from Financing Activities

    Back to Cashflow Statement
COMMUNITY POLL
for WINDLAS BIOTECH
Please provide your vote to see the results

WINDLAS BIOTECH Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Cash Flow from Financing Activities ₹-13 Cr₹1.01 Cr₹-15 Cr₹-44 Cr₹130 Cr

What is the latest Cash Flow from Financing Activities ratio of WINDLAS BIOTECH ?

The latest Cash Flow from Financing Activities ratio of WINDLAS BIOTECH is ₹-13 Cr based on Mar2026 Consolidated results.
Year Cash Flow from Financing Activities
Mar2026₹-13 Cr
Mar2025₹1.01 Cr
Mar2024₹-15 Cr
Mar2023₹-44 Cr
Mar2022₹130 Cr

How is Cash Flow from Financing Activities of WINDLAS BIOTECH Trending?

Years Cash Flow from Financing Activities % Change
Mar2026 ₹-13 Cr
Negative
Mar2025 ₹1.01 Cr
Positive
Mar2024 ₹-15 Cr
Negative
Mar2023 ₹-44 Cr
Negative
Mar2022 ₹130 Cr -

Compare Cash Flow from Financing Activities of peers of WINDLAS BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
WINDLAS BIOTECH ₹1,952.8 Cr -6.9% -17.5% 5.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹421,539.0 Cr -1.4% -6.6% 7.3% Stock Analytics
DIVIS LABORATORIES ₹247,576.0 Cr 1.2% -2.6% 60% Stock Analytics
TORRENT PHARMACEUTICALS ₹177,251.0 Cr -2% -6.1% 33% Stock Analytics
CIPLA ₹105,290.0 Cr -2.3% -5.8% -13.9% Stock Analytics
DR REDDYS LABORATORIES ₹99,752.6 Cr -1.1% 3.8% -5.5% Stock Analytics


WINDLAS BIOTECH Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
WINDLAS BIOTECH

-6.9%

-17.5%

5.5%

SENSEX

0.8%

-4.8%

-10.5%


You may also like the below Video Courses